Bisphosphonate and statin: adverse effects of co-medication on wound healing in in vitro models of periodontal tissues
Acta Odontologica Scandinavica · 2026
DOI: 10.2340/aos.v85.45585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Odontologica Scandinavica, 2026. Verfasst von Agnes Småland-Reksten und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Wound Healing, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Simvastatin, Diphosphonates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Objective
Bisphosphonates and statins may influence wound healing and are frequently prescribed to the same patient group. Bisphosphonates may induce osteonecrosis of the jaw; however, little information is available on the cellular mechanisms and biological effects of co-medication in oral tissues. The aim was to assess the effects of alendronate and simvastatin, both alone and combined, on osteoblasts and gingival fibroblasts in vitro. Study design: Primary human gingival fibroblasts and primary human osteoblasts were incubated with alendronate (5 µM) and simvastatin (1, 5 or 10 µM), alone or combined, for up to 14 days. Cells were assessed for viability by measuring lactate dehydrogenase activity and caspase-3 concentration in the cell culture media. Migration and proliferation potential was assessed by scratch-wound assay. Secreted levels of cytokines/chemokines were measured using Luminex 200 multianalytic profiling.
Results
High concentrations of simvastatin, both alone and combined with alendronate, affected the proliferation/migration potential and reduced scratch closure. The same exposure induced near abolishment of secreted levels of cytokines affecting angiogenesis, such as VEGF, IL-6, IL-8, and MCP-1, however little effect was found on cell viability.
Conclusion
High concentrations of simvastatin, alone or combined with alendronate, may have a negative impact on angiogenetic markers and cell migration/proliferation, affecting wound healing and growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway.
- Department of Biomaterials, Faculty of Dentistry, University of Oslo, Oslo, Norway.
- Oral Research Laboratory, Faculty of Dentistry, University of Oslo, Oslo, Norway.
- Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway. t.b.kruger@odont.uio.no.
Zitieren
APA
Småland-Reksten, A., Agger, A. E., Lian, A. M., Reseland, J. E., & Krüger, T. B. (2026). Bisphosphonate and statin: adverse effects of co-medication on wound healing in in vitro models of periodontal tissues. Acta Odontologica Scandinavica. https://doi.org/10.2340/aos.v85.45585
Vancouver
Småland-Reksten A, Agger AE, Lian AM, Reseland JE, Krüger TB. Bisphosphonate and statin: adverse effects of co-medication on wound healing in in vitro models of periodontal tissues. Acta Odontologica Scandinavica. 2026. doi:10.2340/aos.v85.45585
BibTeX
@article{SmlandReksten2026,
author = {Småland-Reksten, Agnes and Agger, Anne E and Lian, Aina M and Reseland, Janne E and Krüger, Tormod B},
title = {Bisphosphonate and statin: adverse effects of co-medication on wound healing in in vitro models of periodontal tissues},
journal = {Acta Odontologica Scandinavica},
year = {2026},
doi = {10.2340/aos.v85.45585}
}
EUVIMED